Scope of the Commercial License Sample Clauses

Scope of the Commercial License. The exclusive right and license granted under this agreement to the Journal Owner for commercial use is as follows: a. to prepare, reproduce, manufacture, publish, distribute, exhibit, advertise, promote, license and sub-license printed and electronic copies of the article, through the Internet and other means of data transmission now known or later to be developed; the foregoing will include abstracts, bibliographic information, illustrations, pictures, indexes and subject headings and other proprietary materials contained in the article, b. to exercise, license, and sub-license others to exercise subsidiary and other rights in the article, including the right to photocopy, scan or reproduce copies thereof, to reproduce excerpts from the article in other works, and to reproduce copies of the article as part of compilations with other works, including collections of materials made for use in classes for instructional purposes, customized works, electronic databases, document delivery, and other information services, and publish, distribute, exhibit and license the same.
AutoNDA by SimpleDocs
Scope of the Commercial License. The right and license granted under this agreement to the Journal Owner for commercial use is as follows:
Scope of the Commercial License. The exclusive right and license granted under this agreement to the Journal Owner for commercial use is to exercise, license, and sub-license others to exercise subsidiary and other rights in the article, including the right to photocopy, scan or reproduce copies thereof, to reproduce excerpts from the article in other works, and to reproduce copies of the article as part of compilations with other works, including collections of materials made for use in classes for instructional purposes, customized works, electronic databases, document delivery, and other information services, and publish, distribute, exhibit and license the same.
Scope of the Commercial License. The exclusive right and license granted under this agree- ment to the Journal Owner for commercial use is as fol- lows: a. to prepare, reproduce, manufacture, publish, distrib- ute, exhibit, advertise, promote, license and sub- license printed and electronic copies of the article, through the Internet and other means of data trans- mission now known or later to be developed; the fore- going will include abstracts, bibliographic informa- tion, illustrations, pictures, indexes and subject head- materials made for use in classes for instructional pur- poses, customized works, electronic databases, docu- ment delivery, and other information services, and publish, distribute, exhibit and license the same. Where this agreement refers to a license granted to the Journal Owner in this agreement as exclusive, the author commits not only to refrain from granting such license to a third party but also to refrain from exercis- ing the right that is the subject of such license otherwise than by performing this agreement. The Journal Owner will be entitled to enforce in respect of third parties, to such extent as permitted by law, the rights licensed to it under this agreement. If the article was written in the course of employment by the US or UK Government, and/or arises from NIH funding, please consult the Journal Owner for further instructions. Author’s Signature: ings and other proprietary materials contained in the article, b. to exercise, license, and sub-license others to exercise subsidiary and other rights in the article, including the right to photocopy, scan or reproduce copies thereof, to reproduce excerpts from the article in other works, and to reproduce copies of the article as part of com-
Scope of the Commercial License. The Journal Owner will be entitled to enforce in respect of third parties, to such extent as permitted by law, the rights licensed to it under this agreement.
Scope of the Commercial License. The right and license granted under this agreement for commercial use, is as follows, and applies to the Journal Owner exclusively: - to exercise, license, and sub-license others to exercise subsidiary and other rights in the article, including the right to photocopy, scan or reproduce copies thereof, to reproduce excerpts from the article in other works, and to reproduce copies of the article as part of compilations with other works, including collections of materials made for use in classes for instructional purposes, customized works, electronic databases, document delivery, and other information services, and publish, distribute, exhibit and license the same. The Journal Owner will be entitled to enforce in respect of third parties, to such extent as permitted by law, the rights licensed to it under this agreement. If the article was written in the course of employment by the US or UK Government, and/or arises from NIH funding, please consult the Journal Owner for further instructions. Author’s Signature: ......................................................................................................................................... Name printed: ......................................................................................................................................... Date: ......................................................................................................................................... e-mail: xxx-xx-xx@xx.x-xxx.xx Editor-in-Chief: Xxxxxxxxx XXXXXXXXX XXXXXXXXX, Ph. D. E-mail: xxxxxxxxx.xxxxxxxxx@xxxxxx.xx xxxxxxxxx.xxxxxxxxx@xxxxx.xxx Dear Author(s), You are kindly asked to sign this agreement and forward it as an e-mail attachment, fax message or by post, along with submission of your manuscript to Acta Pharmaceutica, or upon request of the Editor. Please note that this is a prerequisite for any editorial/review processing and possible publication of your manuscript. AUTHOR'S AGREEMENT FORM 1. Authorship/contributorship
Scope of the Commercial License. The right and license granted under this agreement to the Journal Owner for commercial use is as follows: x. xx prepare, reproduce, manufacture, publish, distribute, exhibit, advertise, promote, license and sublicense printed and electronic copies of the article, through the Internet and other means of data transmission now known or later to be developed; the foregoing will include abstracts, bibliographic information, illustrations, pictures, indexes and subject headings and other proprietary materials contained in the article, b. to exercise, license, and sub-license others to exercise subsidiary and other rights in the
AutoNDA by SimpleDocs

Related to Scope of the Commercial License

  • Trial License We grant you a free-of-charge, non-assignable, non-sublicensable, non-exclusive, worldwide right and license for one (1) Authorized User to install and use one (1) copy of the Software solely for internal Non-Production purposes to evaluate the Software to determine whether to purchase a license to the Software. You may not download more than one (1) copy of the Software unless otherwise authorized by us. You may not use the Software for any other purpose. You may only use the Software for thirty (30) days from the Effective Date, unless otherwise authorized by us ("Trial Period"). Unless you pay the applicable fee for the Software, the Software may become inoperable and, in any event, your right to use Software automatically expires at the end of the Trial Period. We may terminate your license to the trial version of the Software upon written notice at any time for any reason and without liability of any kind. If you subsequently license a non-trial version of the Software, your license to the trial version of the Software shall immediately terminate.

  • Perpetual License Notwithstanding anything else in the Agreement, Licensor grants to Licensee and Participating Institutions a nonexclusive, royalty-free, system-wide perpetual license limited to the territory of Czech Republic to use any Licensed Materials that were subscribed to or for which a perpetual license fee has been paid during the term of this Agreement. Such use shall be in accordance with the provisions of this Agreement, which provisions shall survive any termination of this Agreement. The means by which Licensee and/or Participating Institutions shall have access to such Licensed Materials shall be in a manner and form substantially equivalent to the means by which access is provided under this Agreement. If the Licensor’s means of access is not available, the Licensee and/or Participating Institutions may provide substantially equivalent access to the Licensed Materials by use of an archival copy or by engaging the services of third-party trusted archives (such as Portico) and/or participating in collaborative archiving endeavors to exercise its perpetual use rights.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!